Can You Take HRT and GLP-1 Together?
Can you take HRT and GLP-1 together? Yes — current FDA labels do not list menopause hormone therapy as a reason you can't take semaglutide or tirzepatide. There's no rule that says you have to pick one. The real question is narrower: whether any of your hormones are a pill — especially oral progesterone if you have a uterus — and whether your GLP-1 is being started or increased.
Here's the honest hook we'll come back to: no completed randomized trial has proven precisely what semaglutide or tirzepatide does to menopause-hormone absorption, bleeding, or the lining of your uterus. The strongest guidance we have leans on careful expert opinion. That actually points to a calm, simple plan — and it all starts with one word: route.
Who this guide is for — and who needs a real person first
This guide is for you if:
- You're on HRT and thinking about a GLP-1 like Ozempic, Wegovy, Mounjaro, or Zepbound.
- You're already on a GLP-1 and want to start HRT.
- You use an estrogen patch but take progesterone as a pill.
- You're about to start a GLP-1, or your doctor is raising your dose.
- You just want the right questions to bring to your appointment.
Talk to a clinician first if:
- You have new or unexplained bleeding after menopause.
- You have persistent severe belly pain, with or without vomiting.
- You might be pregnant.
- You or a close relative has had medullary thyroid cancer, or you have MEN2.
- You've had a serious allergic reaction to semaglutide, tirzepatide, or an ingredient.
- You have severe gastroparesis or another major stomach-emptying disorder.
- You're trying to change your hormone dose on your own.
- Your medicine is compounded and you're not sure what's in it.
The HRT Index is the independent menopause HRT decision resource for women. For this guide, we read the actual FDA prescribing labels for these drugs and the British Menopause Society's 2025 guidance on using them with HRT — so you can get the real answer in one place instead of ten browser tabs.
Which HRT + GLP-1 combination matches your situation?
Skim for your situation. The full “why” is below.
| Your situation | The bottom line |
|---|---|
| Semaglutide (Ozempic/Wegovy) + oral HRT | A general “watch your swallowed meds” caution applies, but the label does not show your HRT stops working. |
| Tirzepatide (Mounjaro/Zepbound) + oral HRT | A stronger reason to review your regimen — tirzepatide has a documented effect on a swallowed birth-control pill. |
| Patch, gel, or spray estrogen + oral progesterone | Your estrogen skips the gut. Your progesterone doesn't — that's the part to check. |
| You have a uterus + take oral progesterone | Make uterine-lining protection a specific question for your prescriber. |
| Combined patch or a hormonal IUD | The gut isn't the main issue here; your overall fit still matters. |
| Your semaglutide is a pill (Wegovy pill or Rybelsus) | Same gut questions, plus a timing rule — keep it separate from your other oral pills. |
| New bleeding or won't-stop vomiting | Call your clinician — don't rely on a general article. |
The right online HRT provider isn't the same for every woman. Use The HRT Index's Find My HRT Path tool to match your situation to the right questions and providers before your first consult.
Can you take HRT and GLP-1 together — and what changes the answer?
The short version: there's no blanket ban on using menopause HRT with semaglutide or tirzepatide, and the two are prescribed together. What changes the answer most is four things — which GLP-1 you take, whether any of your hormones are swallowed, whether you have a uterus, and whether you're just starting or raising your GLP-1 dose. Direct safety data on the exact pairing is still limited.
HRT (hormone replacement therapy) uses estrogen to ease menopause symptoms. If you have a uterus and use whole-body (“systemic”) estrogen, you generally also need a progestogen — the umbrella word for progesterone and the progestins — to protect your uterine lining. You can take these hormones as a pill, a skin patch, a gel, a spray, or a vaginal product.
A GLP-1 slows how fast your stomach empties. Semaglutide (Ozempic and Wegovy) works on the GLP-1 receptor. Tirzepatide (Mounjaro and Zepbound) works on two — the GIP and GLP-1 receptors. They don't clash with HRT in your bloodstream. The one documented concern is about absorption — a GLP-1 slows your stomach, which can change how a swallowed pill is taken up.
Four things decide what, if anything, needs a second look:
- Which GLP-1? Semaglutide and tirzepatide are not the same here.
- Is any hormone a pill? Swallowed hormones can be affected; skin and vaginal hormones can't.
- Do you have a uterus? This changes how serious the progesterone question is.
- Stable dose, or starting/increasing? For tirzepatide, the effect is biggest right after you start or go up a dose.
What “you can take them together” does not mean
It does not mean either drug is right for every woman. It does not mean every combination has been proven safe in a trial. It does not mean you can ignore how swallowed pills are absorbed. And it absolutely does not mean you should change your own progesterone.
What's the actual concern between GLP-1 medicines and HRT?
The main thing documented in the labels is delayed gastric emptying — food and swallowed medicine leave your stomach more slowly. That can change the timing or the amount of a swallowed drug that reaches your blood — sometimes less, sometimes more. It is not the same as proof that your HRT stops working.
A few things to hold onto:
- This effect is not identical for every drug. Some pills barely notice; others shift more.
- It doesn't always mean less. Oral semaglutide actually raised the absorption of levothyroxine by about a third — per the FDA label. So “slower stomach” can mean higher, lower, or just delayed.
- “Changed absorption” is not the same as “doesn't work.” A small shift doesn't automatically equal treatment failure.
- For tirzepatide specifically, the slow-stomach effect is biggest right after the first dose, then fades as your body adjusts.
| A direct drug clash | An absorption / timing concern |
|---|---|
| One medicine changes how another works or breaks down in your body. | A slower stomach changes when or how much of a swallowed pill reaches your blood. |
| Not the main issue between HRT and GLP-1s — FDA labels don't flag a direct clash. | This is the issue the labels and guidance flag. |
| Would matter no matter how you take it. | Mostly matters for things you swallow. |
So we're not talking about a chemical fight in your bloodstream. We're talking about a swallowed pill maybe getting absorbed differently. For menopause HRT, the swallowed hormone that matters most here is oral progesterone.
Is semaglutide different from tirzepatide when you take HRT?
Yes — don't treat them as the same drug for this question. Semaglutide's label carries a general “monitor swallowed medicines” caution, and a 2015 study found it did not meaningfully change the levels of the tested birth-control hormones. Tirzepatide goes further: its label documents a real drop in how much of a swallowed birth-control pill gets absorbed.
Semaglutide (Ozempic and Wegovy)
Semaglutide slows your stomach, like all GLP-1s. Its label says to watch swallowed medicines that need careful monitoring or have a narrow safety margin. But when researchers actually tested it with a combined birth-control pill in 2015, they found no clinically significant changein the tested hormones — ethinyl estradiol and levonorgestrel (Kapitza et al., 2015). Important: that was a contraceptive study, not a test of menopause oral estrogen or progesterone. There's no direct evidence that semaglutide makes menopause HRT fail — and it also hasn't been directly tested. If you're throwing up a lot, your symptoms shift, or you have unexpected bleeding, those are worth reporting.
Ozempic and Wegovy contain the same drug (semaglutide) at different doses — Ozempic for type 2 diabetes, Wegovy for weight management (and to lower cardiovascular risk). Semaglutide now also comes as a pill — more below.
Tirzepatide (Mounjaro and Zepbound)
Tirzepatide is the one to slow down on. Its stomach-slowing effect is strongest after the very first dose. In the drug-interaction study on its label, a single 5 mg dose taken with a combined birth-control pill cut the total amount of hormone absorbed by about 20–23%, dropped the peak level by about 55–66%, and delayed that peak by 2.5–4.5 hours — per the FDA label for Mounjaro and Zepbound. Because of that, the label tells women on oral birth control to switch to a non-pill method, or add a barrier method, for 4 weeks after they start and after every dose increase.
What about other GLP-1 drugs?
Don't assume another GLP-1 acts exactly like tirzepatide. Liraglutide and dulaglutide did notshow a meaningful effect on contraceptive hormone levels, while exenatide and lixisenatide have been linked to a reduced contraceptive effect (Skelley et al., 2024). If your drug isn't semaglutide or tirzepatide, check that specific product's current label.
Our GLP-1 evidence table
Separated by what's in the FDA labels vs what's only been studied for birth control — not menopause HRT.
| GLP-1 drug (brands) | What's documented for swallowed hormones | What this means for your HRT | Evidence |
|---|---|---|---|
| Tirzepatide (Mounjaro, Zepbound) | With a tested birth-control pill: total amount absorbed down ~20–23%, peak down ~55–66%, peak delayed 2.5–4.5 hrs after first dose; effect fades over time. Label: add backup birth control for 4 weeks after start and each dose increase. | Strongest reason to review oral HRT — especially oral progesterone — around starting and dose changes. Not proof your HRT fails. | FDA-label fact (tested on a contraceptive, not menopause HRT) |
| Semaglutide (Ozempic, Wegovy, and now pills) | No clinically significant change in tested contraceptive hormones (ethinyl estradiol, levonorgestrel) in a 2015 study. General “monitor swallowed meds” caution. | No direct evidence your oral HRT fails. Report ongoing vomiting, symptom changes, or unexpected bleeding. | FDA-label fact + study (contraceptive, not menopause HRT) |
| Liraglutide / Dulaglutide | No meaningful effect on tested contraceptive hormone levels. | Same general caution; no documented hormone-level drop. | Study finding |
| Exenatide / Lixisenatide | Linked to a reduced contraceptive effect. | Check the specific product label before assuming. | Study finding |
Does it matter if your semaglutide is a pill?
Yes — and this is new for 2026, so a lot of older articles miss it. Semaglutide now comes as a pill: the Wegovy pill (oral semaglutide for weight, FDA-approved in December 2025) and Rybelsus (oral semaglutide for type 2 diabetes). Oral semaglutide still slows your stomach like the injection, so the same gut questions apply to any HRT you swallow. On top of that, oral semaglutide has its own strict timing rule.
Oral semaglutide has to be taken on an empty stomach with a small sip of plain water, and you wait at least 30 minutes before any food, drink, or other oral medicine — per the label. That rule exists so the semaglutide itself gets absorbed. If you take oral semaglutide andan oral HRT pill, don't swallow them at the same moment. Space them out the way your product's instructions say, and ask your prescriber or pharmacist how to line up the timing.
Note:The route logic for your HRT doesn't change. A patch, gel, spray, or vaginal estrogen still skips the gut — whether your semaglutide is a shot or a pill.
Does your HRT route change the answer?
Yes — and this is the single most useful thing on this page. Because this whole issue is about the gut, hormones that skip the gut aren't part of it. Estrogen through your skin (patch, gel, spray) or used vaginally doesn't depend on stomach emptying, so a GLP-1's slow-stomach effect doesn't reach it. Hormones you swallow can be affected.
The rule is short: swallowed = can be affected. Skin or vaginal = outside this issue.
Your HRT route, decoded
| How you take it | Goes through your gut? | Affected by a GLP-1's slow-stomach effect? | What to do |
|---|---|---|---|
| Estrogen pill | Yes | Possibly | Worth asking whether a skin route would be steadier. |
| Estrogen patch, gel, or spray | No | Not by this issue | No change needed just for this. |
| Low-dose local vaginal estrogen | No | Not by this issue | Acts locally; verify your exact product. |
| Systemic vaginal estrogen (e.g., higher-dose ring) | No (transmucosal) | Not by this issue | It's whole-body estrogen — identify the product separately. |
| Oral progesterone (a capsule) | Yes | Possibly | The key one if you have a uterus — see the next section. |
| Combined estrogen-progesterone patch | No | Not by this issue | Gut isn't the concern; overall fit still matters. |
| Hormonal IUD (releases progestin in the uterus) | No | Not by this issue | Not affected by a GLP-1. |
Trying to figure out whether online care fits your route, state, and history?
Our matching tool finds a care model that fits — it does not give you personal drug-interaction clearance.
Get your personalized HRT path →Free · Private · No diagnosis · Flags when in-person care comes first
What if you have a uterus and take oral progesterone?
This is the highest-stakes part of the whole question. If you have a uterus and use systemic estrogen, you also need enough progestogen to protect your endometrium— the lining of your uterus. Without that protection, estrogen alone can make the lining overgrow, which raises the risk of endometrial hyperplasia and cancer. If a GLP-1 reduces how well swallowed progesterone is absorbed, the real worry isn't your hot flashes — it's whether that protection still holds.
Estrogen tells your uterine lining to build up. Progestogen keeps that build-up in check. That's a safety feature, not a comfort feature. So if there's any chance a GLP-1 lowers how much swallowed progesterone you actually absorb, the question becomes: is my lining still protected?
What the British Menopause Society actually says
The most specific professional guidance on this exact pairing comes from the British Menopause Society, updated in 2025. In plain terms, it tells clinicians:
- It prefers moving the progestogen to a non-oral route for the whole time you're on a GLP-1.
- Around starting and each dose increase, a clinician can either use a non-oral progestogen, or temporarily adjust the oral progestogen — a doctor's call, not a do-it-yourself one.
- A 52 mg levonorgestrel IUD is likely the most complete option — it protects the lining, isn't affected by GLP-1s, and provides birth control if you can still get pregnant.
- Combined estrogen-progestogen patches and vaginal progesterone are likely unaffected too.
- This is explicitly expert opinion, drawn partly from birth-control data, not menopause-HRT trials — and no data establish exactly what oral dose is needed.
What this guidance does not establish
- It does not prove your oral progesterone has failed.
- It is UK expert guidance, not a U.S. FDA dosing rule. Major U.S. groups haven't issued the same specific advice yet.
- It does not give you a dose to take.
- US specifics worth knowing: the 52 mg hormonal IUD (like Mirena) is FDA-approved here for birth control and heavy periods — using it for menopause lining-protection is common but off-label. Vaginal progesterone products in the U.S. are approved for fertility treatment, not menopause lining-protection — also off-label.
Questions worth asking your prescriber:
- Is any part of my HRT something I swallow?
- Do I rely on oral progesterone to protect my uterine lining?
- Does the answer change because I'm on tirzepatide versus semaglutide?
- Does starting or increasing my GLP-1 change my plan?
- What kind of bleeding should I report, and how fast?
- Would a non-oral progestogen (or a hormonal IUD) make sense for me?
Want to walk in sounding like you know what you're talking about?
Answer a few quick questions about your route and your drug — build a short list to hand your prescriber. No account, no email, your answers stay in your browser.
Build your HRT + GLP-1 question list →Should you switch from HRT pills to a patch, gel, or IUD?
Don't switch routes or change your progesterone on your own — that's a decision to make withyour prescriber. A non-oral route can take the absorption question off the table for that hormone, which is genuinely useful. But the best regimen still depends on your symptoms, whether you have a uterus, your health history, your preferences, and what's available to you.
Step 1
Is any hormone something you swallow?
No → the gut isn't your main issue; focus on whether each drug is right for you. Yes → figure out whether it's estrogen, progesterone, or both.
Step 2
Do you have a uterus?
Yes → identify how your lining is protected (oral progesterone? combined patch? IUD?). No → the lining question mostly drops away; move to general fit.
Step 3
Which GLP-1, and is it a shot or a pill?
Tirzepatide → flag the start and every dose increase. Semaglutide injection → general “watch swallowed meds.” Oral semaglutide → add the timing rule. Other → check that label.
Step 4
Any new bleeding or won't-stop vomiting?
Yes → call your clinician instead of working from a flowchart. No → bring the routine questions to your next visit.
One more fair point: a clinician might still keep you on an oral route on purpose — because it controls your symptoms well, because of cost or availability, or because of your specific history. Non-oral isn't automatically “better.” It just removes one variable.
Can HRT make semaglutide or tirzepatide work better for weight loss?
Maybe — and this is the hopeful part, with an honest asterisk. In real-world studies, postmenopausal women who used hormone therapy alongside a GLP-1 lost more weight than those who didn't. But these are observational studies — they show the two things go together, not that HRT causedthe difference. HRT is not a weight-loss drug, and it shouldn't be started just to lose weight.
Semaglutide + HRT (Hurtado et al., Menopause, 2024)
106 postmenopausal women (only 16 on hormone therapy). At 12 months: ~16% body-weight loss with HRT vs ~12% without. Small, not randomized.
Tirzepatide + HRT (Bechenati, Castaneda et al., Lancet OGW&H, 2026)
120 postmenopausal women. ~19% body-weight loss with HRT vs ~14% without. More reached the 20%+ milestone. Observational.
This is a promising reason to feel good about the combination if your clinician already thinks HRT is right for you — not a reason to start HRT as a weight-loss shortcut. A registered clinical trial is now studying semaglutide together with menopause hormone therapy, but it hasn't reported results yet. See also our broader weight-care guide.
What risks and side effects deserve extra attention?
No combination-specific safety problem has turned up in direct studies of HRT plus a GLP-1 — partly because direct studies of the pairing are still limited. The smart approach is to watch the known risks of each medicine, plus the ways their side effects can muddy the picture.
Nausea, vomiting, and dehydration
Stomach upset is common with GLP-1s, especially early. If you're throwing up a lot, you may not fully absorb a swallowed pill that day — and you can get dehydrated. Persistent symptoms are worth a call. Don't invent your own dose changes to compensate.
Unexpected bleeding
Don't assume it proves an interaction — and don't shrug it off as “just the GLP-1,” either. Write down the timing: when you changed your HRT, when you started or increased the GLP-1, and the bleeding pattern. New or unexplained bleeding after menopause should always be checked.
Persistent severe belly pain
Get it looked at promptly — serious stomach, gallbladder, or pancreas problems need quick attention.
Surgery and anesthesia
Tell any surgical or anesthesia team you're on a GLP-1. Because GLP-1s slow your stomach, food can sit longer than expected — which matters for sedation and anesthesia. Don't rely on a one-size-fits-all “stop X days before” rule from the internet; that guidance keeps changing and should come from your procedure team.
Pregnancy and birth control — a separate issue
HRT is not birth control. If you're perimenopausal, you can still get pregnant. GLP-1s can make the pill less reliable — most with tirzepatide, and most around starting and dose increases — and weight loss itself can restore fertility. “Ozempic babies” are a real phenomenon. The labels say to stop semaglutide at least 2 months before a planned pregnancy (it lingers in the body). If you could become pregnant, you need a contraception plan of your own, separate from your HRT.
If your medicine is compounded
Compounded GLP-1s and hormones are not FDA-approved and aren't reviewed before sale for safety, effectiveness, or quality. The FDA label facts we've discussed describe the FDA-approved products; they can't be assumed to apply to a compounded version. If you're not sure what you have, ask your prescriber and pharmacist.
Can you start HRT and a GLP-1 at the same time?
There's no rule requiring you to wait between starting HRT and a GLP-1. But spacing the changes out can make life easier. When you change two things together, it's harder to tell which one caused a side effect, a symptom shift, or some bleeding. A clinician may prefer to stage the changes — especially with oral HRT, a uterus to protect, tirzepatide dose increases, or other risk factors in the mix.
The case for changing one thing at a time: easier to know what caused a side effect; easier to see how each medicine is working; easier to read a bleeding pattern; easier to remember doses.
What should your clinician review before you combine them?
A good medication review writes down the specifics: your exact GLP-1, every hormone and how you take it, whether you have a uterus, how your lining is protected, your current dose stage, your bleeding pattern, and your other swallowed medicines. The goal isn't a generic “yes.” It's to leave with a real plan for symptoms, bleeding, dose increases, and follow-up.
About your medicines
- Generic and brand name of each
- FDA-approved or compounded?
- Dose and how often
- When you started; most recent dose increase
- How you take each hormone (pill/patch/gel/spray/vaginal/IUD); shot or pill GLP-1
- Which clinician prescribes which
- Other pills and supplements you swallow
About your HRT
- Whether you have a uterus
- Why you're on HRT
- Your estrogen route
- Your progesterone route
- Your current bleeding pattern
- Any return of symptoms after a change
About your GLP-1
- Semaglutide, tirzepatide, or something else — shot or pill
- Why you're taking it
- Current dose stage (starting, increasing, steady)
- Any stomach side effects or vomiting
- Any upcoming surgery or procedure
Then ask for a plan you can actually use: what to track, what bleeding to report, when your next review is, and who's in charge if two different clinicians prescribe the two medicines.
Ready to create your pre-consult checklist?
Turn your routes and dose stage into a printable page — no account needed.
Create your pre-consult checklist →When should you call a clinician right away?
Call your clinician soon if you have:
- New or unexplained bleeding
- Symptoms that came back after a medication change
- Repeated vomiting, or you can't keep your pills down
- Stomach symptoms that won't settle
- Worry that your birth control isn't working, or you might be pregnant
- Doubt about what's actually in a compounded product
Get urgent or emergency care for:
- Persistent severe belly pain
- Chest pain or trouble breathing
- Sudden weakness, drooping face, slurred speech, or other serious nerve symptoms
- Signs of a serious allergic reaction
- Severe dehydration, or you can't keep any fluids down
How we checked this
We sorted every important claim by how solid the evidence is, and we tell you which is which. Some statements are FDA-label facts. Some are recommendations from a professional society. Some come from observational studies that show a link but can't prove cause. And some questions simply haven't been directly studied yet. You can read more about how we work on our methodology page.
What we checked (June 2026):
- The current FDA prescribing information for the semaglutide and tirzepatide products, including the new oral semaglutide products approved for 2026.
- The FDA label language on swallowed-medicine absorption and the tirzepatide birth-control finding.
- The British Menopause Society's 2025 guidance on using these drugs with HRT (and the underlying medical-journal article).
- The 2024 Menopause study on semaglutide and hormone therapy.
- The 2026 Lancet Obstetrics, Gynaecology & Women's Health study on tirzepatide and hormone therapy.
- ACOG and The Menopause Society on estrogen route and local vaginal estrogen.
- The FDA's information on compounded GLP-1 medicines.
What we did not do: We did not test these medicines ourselves, review your personal medical record, create a dosing plan for you, or treat online anecdotes as medical evidence. This guide is editorial research and is not medically reviewed by a clinician. Spot an error? Tell us.
Frequently asked questions
- Can you take HRT and Ozempic together?
- Usually, yes. Ozempic (semaglutide) didn't meaningfully change the tested contraceptive hormones in studies, and it doesn't affect skin or vaginal estrogen. If any of your HRT is oral, mention it to your prescriber, and coordinate both medicines.
- Can you take HRT and Wegovy together?
- Yes, with the same considerations — Wegovy is also semaglutide. If your Wegovy is the pill, keep it separate from your other oral pills by the time your label says. Skin and vaginal estrogen aren't affected either way.
- Can you take HRT and Mounjaro together?
- You can, but review your swallowed HRT, because tirzepatide (Mounjaro) has a documented effect on a tested birth-control pill around starting and dose increases. Skin and vaginal estrogen aren't affected.
- Can you take HRT and Zepbound together?
- Yes, it's not banned. But oral HRT — especially oral progesterone if you have a uterus — deserves a specific review when you start Zepbound (tirzepatide) or raise the dose.
- Does semaglutide affect progesterone absorption?
- Semaglutide slows the stomach, but direct studies on menopause oral progesterone are lacking, so no one can say it definitely lowers your levels. If you swallow your progesterone and have a uterus, it's still worth a prescriber review.
- Does tirzepatide affect oral progesterone?
- Tirzepatide reduced the absorption of a tested birth-control pill, and experts worry the same could apply to oral progesterone — but it hasn't been proven in a menopause-HRT trial. It's a strong reason to review, not a confirmed failure.
- Can a GLP-1 make HRT less effective?
- It can change how some swallowed pills are absorbed, but 'less effective' isn't established for every HRT product, and skin or vaginal routes aren't affected by this issue. Your drug, your route, and your symptoms all matter.
- Is an estrogen patch affected by a GLP-1?
- No — a patch sends estrogen straight into your blood and skips the gut, so a GLP-1's slow-stomach effect doesn't reach it. Just check whether you also take oral progesterone or another swallowed medicine.
- What if I only use vaginal estrogen?
- Low-dose local vaginal estrogen works mainly right where you put it and isn't affected by this issue, and it's different from whole-body HRT. Confirm your exact product, since a few vaginal products are systemic.
- Does it matter if my semaglutide is a pill instead of a shot?
- Yes. Oral semaglutide (the Wegovy pill or Rybelsus) still slows your stomach, and it has a timing rule — take it on an empty stomach and wait at least 30 minutes before food, drink, or other oral pills, including oral HRT.
- Why did my hot flashes come back after starting a GLP-1?
- There can be several reasons, and one person's experience doesn't prove an interaction. Note the timing, any vomiting, weight change, and any HRT change, then talk to your prescriber — especially if your estrogen is oral.
- Why did I start bleeding after a GLP-1 dose change?
- Don't try to diagnose the cause online. New or unexplained bleeding should be checked by a clinician, particularly if you're on systemic estrogen or oral progesterone.
- Should I take my progesterone at a different time of day?
- Don't change the timing on your own — ask your prescriber. There's no proven 'time it differently' workaround for this.
- Should I increase my progesterone dose?
- That's not something to do yourself. A clinician-facing guideline discusses how a doctor might adjust, but there's no universal patient dose, and the evidence is limited.
- Can I start HRT and a GLP-1 on the same day?
- You can, but spacing the changes out can make side effects and bleeding much easier to understand. There's no proven 'right' order.
- Does HRT improve GLP-1 weight loss?
- Observational studies show women on hormone therapy lost more weight, but they can't prove HRT caused it — treat it as a promising signal, not proof, and not a reason to start HRT for weight loss.
- What if my GLP-1 or HRT is compounded?
- FDA-approved label facts can't be assumed to apply to compounded products, which aren't FDA-approved. If you're unsure what's in yours, ask your prescriber and pharmacist.
- Do both of my prescribers need to know?
- Yes. Every prescriber and your pharmacist should have an accurate, up-to-date list of your medicines, including how you take each one and any recent dose changes.
You came here worried these two medicines might clash. Here's where you can land instead: knowing your route, knowing the one thing to check if any hormone is oral, and knowing the exact questions to bring to your prescriber. That's a calm, in-control place to be — and it's a much better starting point than guessing.
Still not sure which HRT program is right for you?
Take our free 60-second matching quiz — no provider pitch before you see your result.
Find My HRT Path →Sources
Last verified: June 25, 2026.
- FDA prescribing information, Mounjaro and Zepbound (tirzepatide), Eli Lilly — delayed gastric emptying greatest after first dose; with a combined oral contraceptive (ethinyl estradiol 0.035 mg + norgestimate 0.25 mg), Cmax reduced 59%/66%/55% and AUC reduced 20%/21%/23% with Tmax delayed 2.5–4.5 hrs; add non-oral or barrier contraception for 4 weeks after initiation and each dose escalation; Zepbound obstructive-sleep-apnea indication. (DailyMed/accessdata.fda.gov.)
- FDA prescribing information, Ozempic and Wegovy (semaglutide), Novo Nordisk — delayed gastric emptying; monitor concomitant oral medicines; discontinue at least 2 months before a planned pregnancy.
- FDA approval of oral semaglutide (Wegovy pill), December 22, 2025; Rybelsus (oral semaglutide) prescribing information — empty-stomach administration and ≥30-minute separation from food, drink, and other oral medicines; oral semaglutide increased levothyroxine exposure ~33%.
- Kapitza C, et al. J Clin Pharmacol. 2015;55(5):497–504 — semaglutide does not reduce bioavailability of a combined oral contraceptive (ethinyl estradiol/levonorgestrel).
- Skelley JW, et al. J Am Pharm Assoc. 2024 — effects of tirzepatide and GLP-1 receptor agonists on oral hormonal contraception (liraglutide/dulaglutide no meaningful effect; exenatide/lixisenatide linked to reduced effect).
- British Menopause Society — “Use of incretin-based therapies in women using HRT,” updated 19 May 2025; Mukherjee A, Ghaem-Maghami S, Syed AA, Post Reproductive Health, 2025 (doi:10.1177/20533691251343069). Primary concern is endometrial protection via reduced oral-progestogen absorption; non-oral progestogen preferred; 52 mg levonorgestrel IUD likely most comprehensive; expert opinion, limited direct data.
- American College of Obstetricians and Gynecologists; The Menopause Society — estrogen route of administration (transdermal/vaginal bypass gastrointestinal conversion) and distinction of low-dose local vaginal estrogen from systemic therapy.
- Hurtado MD, et al. Menopause. 2024;31(4):266–274 — 106 postmenopausal women (16 on hormone therapy, 90 not); at 12 months ~16% vs ~12% total body-weight loss with semaglutide; not randomized.
- Bechenati D, Castaneda R, et al. The Lancet Obstetrics, Gynaecology & Women's Health. 2026;2(2):e118 — 120 postmenopausal women on tirzepatide; ~19.2% vs ~14.0% body-weight loss with vs without hormone therapy; observational.
- U.S. Food and Drug Administration — compounded drugs are not FDA-approved and are not reviewed before marketing for safety, effectiveness, or quality; compounded GLP-1 use limited to when an FDA-approved drug cannot meet a patient's needs.
The HRT Index — the independent menopause HRT decision layer for women. Educational only, not medical advice. FDA-approved and compounded options are always labeled distinctly, and compounded is never described as equivalent to, safer than, or more natural than FDA-approved medication.
